drugset / Trial / NCT06989268

Effect to Linaclotide on Colonic Motility

NCT06989268

Phase 4 Completed 10 enrolled Universitaire Ziekenhuizen KU Leuven
RandomizedCrossoverTriple-blindOther

Summary

This study aim was to evaluate the effect of Linaclotide, a pharmacological treatment normally used to treat functional constipation or irritable bowel syndrome with predominant constipation, on colonic motility as assessed by high-resolution colonic manometry.

Timeline

Start
2014-02-10
Primary completion
2015-02-15
Completion
2015-06-03

Drugs

EvaluationDrugModalityDoseRoute
Comparator Linaclotide Peptide 290 ug Oral

Indications